Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Comment by longonMJon Nov 13, 2018 2:29am
114 Views
Post# 28963414

RE:Amazing financials and yet sub $10

RE:Amazing financials and yet sub $10Well, I guess it might just depend ypon the definition of amazing.

What you see as amazing financials might just NOT be that amazing from a forecasted target point of view.  After all, although their top line total sales revenue for 2019 Q1 may have seen an increase of 260 YOY, it still amounted to only $29M dollars.

Since the forecasted target for Aurora's sales revenue for the 2019 fiscal year is a tad over $400M, that leaves a whole ton of weed to sell for the remaining 3 quarters.  Although I am sure that sales will indeed be higher for 2019 Q2, I believe the top line sales revenues are going to be negatively affected for all of the LP's (including Aurora) by the poor supply chain system which is one of the reasons for the empty shelves in the stores and online counters.

So, even if they double their sales revenues for Q2, this means they are still going to have to hit over $150M per quarter for the last 2 quarters if they hope to meet their forecasted total.  That might be a pretty tall order for them and all of the other major LP's to meet.

Badtrader2008 wrote: Its like this stock is allergic to staying above $10 sp for more than a few days to a week,

How can it have such a wonderful earnings q1 2019 and have the market respond by closing less than $9.36. Talk about undervaluation.


Bullboard Posts